Thursday, September 25, 2014

from ASCO 2014: Treatment of renal cancer

Renal cell cancer

                      setting                          phase III                                             Alternative
                                                           Sunitinib
1st line         Good or Intermediate      Avastin                                               HD-IL-2
                                                           Interferon-alpha
                                                            Pazopanib
                    Poor risk                   Tamsirolimus

================================================================
           Prior Cytokine                      Sorafenib                                           Sunitinib
                                                         Pazopanib                                         Avastin

2nd line      Prior EGFR                Everolimus
therapy       inhibitor                      Axitinib                                             clinical trial

                   Prior MTOR               Clinical trial

From ASCO



Post a Comment